These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 384893

  • 21. [Stimulating effect of prodigiozan on nonspecific reactivity in typhoid fever, dysentery and staphylococcal infection].
    Kuz'min VG, Loban KM, Medvedeva MM.
    Antibiotiki; 1978 Mar; 23(3):264-8. PubMed ID: 345961
    [Abstract] [Full Text] [Related]

  • 22. [Use of sodium nucleinate and its combinations with bacterial polysaccharides for preventing the nephrotoxic action of aminoglycoside antibiotics].
    Salakaia RG, Amirian NB.
    Antibiotiki; 1984 Jul; 29(7):507-9. PubMed ID: 6486749
    [Abstract] [Full Text] [Related]

  • 23. [Use of lysozyme and prodigiozan in the treatment of suppurative infections in diabetics].
    Nuzov BG.
    Vestn Khir Im I I Grek; 1984 Apr; 132(4):62-5. PubMed ID: 6730182
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Effect of pyrimidine derivatives on the phagocytic ability of the reticuloendothelial system and effectiveness of levomycetin therapy of experimental infection].
    Alekhin EK, Plechev VV.
    Antibiotiki; 1970 Jun; 15(6):540-4. PubMed ID: 5458637
    [No Abstract] [Full Text] [Related]

  • 29. [Effect of gentamycin in combination with prodigiozan on the immunological reactivity of the body].
    Shcherbakova EG, Rastunova GA, Vvedenskaia OI, Zhuravleva TP, Medvedeva MM.
    Antibiotiki; 1979 Sep; 24(9):679-84. PubMed ID: 573585
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Interferonogenic properties of prodigiozan and its effectiveness in treating acute respiratory diseases in children].
    Povolotskiĭ IaL, Andrushchuk AA, Korzhenevskiĭ AF, Krivokhatskaia LD.
    Antibiotiki; 1980 Jul; 25(7):531-4. PubMed ID: 6157358
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Effect of comprehensive antibacterial therapy in combination with prodigiozan on energy metabolic indices in children and adolescents with pulmonary tuberculosis].
    Kshanovs'kyĭ SA, Rushchak VA, Maliuk VI, Vel'tman RV, Polner RA.
    Pediatr Akus Ginekol; 1979 Jul; (3):16-8. PubMed ID: 379787
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Pharmacological analysis of the mechanism of action of prodigiozan].
    Alekhin EK, Kalimullina DKh.
    Antibiotiki; 1983 Jun; 28(6):442-5. PubMed ID: 6309077
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Effectiveness of thymalin and prodigiozan in the complex treatment of patients with dysentery].
    Boĭko IN, Khavinson VKh, Morozov VG.
    Voen Med Zh; 1985 Jul; (7):45-6. PubMed ID: 3901509
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.